LOOMIS SAYLES & CO L P - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$58,221,000
+43.1%
1,560,057
-2.0%
0.07%
+34.0%
Q1 2021$40,696,000
+34.7%
1,591,568
+16.1%
0.05%
+32.5%
Q4 2020$30,209,000
+58.6%
1,371,272
+29.6%
0.04%
+42.9%
Q3 2020$19,042,000
+3.4%
1,058,455
+46.0%
0.03%
-6.7%
Q2 2020$18,415,000725,0030.03%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders